SlideShare a Scribd company logo
Atherosclerosis in Systemic Lupus Erythematosus Maureen McMahon, MD, MCR Assistant Professor of Medicine David Geffen School of Medicine UCLA
Overall Survival in Lupus has   Improved   Gabriel, S. et al.,  Arthritis Rheum 1999;42:46-50. 1950-1979   1980-1992
Late Deaths in SLE are due to Heart Disease (Atherosclerosis) Abu-Shakra M, et al.  J Rheum.  1995;22:1265–1270. [Evidence Level B]
There is an Increased Risk for  Atherosclerosis (ATH) in SLE CVA = cerebrovascular accident. Esdaile JM, et al.  Arthritis Rheum . 2001;44:2331–2337 [Evidence Level B]; Karrar A, et al.  Semin Arthritis Rheum . 2001;30:436–443 [Evidence Level C]; Manzi S, et al.  Am J Epidemiol . 1997;145:408–415 [Evidence Level B]; Manzi S, et al.  Arthritis Rheum . 1999;42:51–60. [Evidence Level B]
Prevalence of ATH Plaque Among Control Subjects and Patients With SLE, According to Decade of Life Roman MJ, et. al.  N Engl J Med . 2003;349:2399–2406. [Evidence Level B]  4th 5th 6th  7th Decade of Age P  = .009 P  = .01 P  = .001 P  = .08
Why do SLE patients have an increased risk of Heart Disease?
Patients with SLE Do Have Traditional Cardiac Risk Factors Petri et al. Medicine 1992
Traditional Risk Factors Do Contribute to ATH in SLE % of patients with plaque, age adjusted p=0.05 p=0.0001 p=0.07 Maksimowicz-McKinnon et al. J Rheum 2006
SLE Disease Activity Influences Standard Lipid Levels Posadas-Romero et al.  Arthritis Rheum . 2004;50:160-165 .
Influence of treatment on lipid levels in SLE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Prevalence and Risk Factors of Carotid Plaque in SLE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
Traditional Framingham Risk Factors Do Not Fully Explain Risk of ATH in SLE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Esdaile JM, et al.  Arthritis Rheum . 2001;44:2331–2337. [Evidence Level B]
Hypothesis  ,[object Object],Ansell et al.  Circulation 2003 Could “Pro-Inflammatory HDL be a factor in SLE??
LDL: the “Bad Cholesterol” LDL Mackness MI et al.  Biochem J  1993. Lipids Online 2004 (Baylor) Blood Vessel White Blood Cells: Monocytes White Blood Cell: Macrophage HDL are anti-inflammatory Foam  Cell HDL Remove “Bad Cholesterol” HDL Prevent Oxidation of LDL Oxidized LDL PLAQUE
Pro-Inflammatory HDL Assay DCFH  (chemical that turns green when oxidized) LDL Fluorescent Signal Patient HDL (normal) -- + Patient HDL (pro-inflammatory) ,[object Object],[object Object],[object Object]
 
Populations of Women studied ,[object Object],[object Object],[object Object],[object Object]
45% of SLE patients have pro-inflammatory HDL
Pro-inflammatory HDL may be associated with heart disease 4 patients with a history of heart attack were  included (all patients had SLE): All 4 had pro-inflammatory HDL!
Populations of Women studied ,[object Object],[object Object],[object Object],All subjects had blood drawn to measure HDL function All subjects had a carotid artery ultrasound to look for thickening of the arteries, or “plaque”
 
86% of SLE patients with ATH have piHDL * Chi-squared or Fisher’s Exact
Presence of piHDL Greatly Increases Risk for Carotid Plaque in SLE ,[object Object],[object Object]
Summary ,[object Object],[object Object],[object Object],Pro-Inflammatory HDL are significantly associated  with plaque on carotid ultrasound in women with SLE but not in healthy controls. Pro-Inflammatory HDL may be one marker that can be used  to predict which patients are at risk for ATH
Future Research Directions ,[object Object],[object Object]
What Can Lupus Patients Do to Decrease Their Risk of Heart Disease?
Ways to Improve ATH Risk Factors Without Medications ,[object Object],[object Object],[object Object],[object Object]
Control High Blood Pressure ,[object Object],[object Object],[object Object],[object Object],[object Object]
NIH CV Risk Calculator
hp2010.nhlbihin.net/atpiii/ calculator .asp
 
Status of Statins in Rheumatic Diseases ,[object Object],[object Object],[object Object],McCarey et al.  Lancet . 2004;363:2015-2021
Statins in SLE ,[object Object],[object Object],[object Object],[object Object],[object Object],Petri et al.,  Arthritis Rheum 2006; 54: suppl 1246
Summary of Statins in Rheumatology Practice ,[object Object],[object Object],[object Object],[object Object]
Antimalarial Drugs and Heart disease in SLE ,[object Object],[object Object],[object Object],Rahman P, et al.  J Rheum . 1999;26:325–330. [Evidence Level B]
Hydroxychloroquine in SLE ,[object Object],[object Object],[object Object],Fessler BJ et al. , Arth Rheum 05;  Ho KT et al. , Rheumatol 2005;  Rahman et al.,  J Rheum 1999.; Roman et al NEJM 2003
Conclusions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
If you or a friend are interested in participating in the carotid ultrasound /piHDL study: ,[object Object],[object Object],[object Object]
Acknowledgements UCLA Rheumatology Bevra Hahn, M.D. Christina Charles, M.D. Jennifer Grossman, M.D. John FitzGerald, M.D., Ph.D. Weiling Chen, M.S. UCLA Cardiology Alan Fogelman, M.D. Mohamad Navab, Ph.D. Cedars-Sinai Medical Center Daniel Wallace, M.D. Michael Weisman, M.D. UCLA Radiology Nagesh Ragavendra, M.D. Funding Organizations Lupus Research Institute Alliance for Lupus Research The Arthritis Foundation

More Related Content

What's hot

Heart Failure in Women: More than EF?
Heart Failure in Women: More than EF?Heart Failure in Women: More than EF?
Heart Failure in Women: More than EF?
ahvc0858
 
Aspirin for primary prevention in cad in type II DM
Aspirin for primary prevention in cad in type II DMAspirin for primary prevention in cad in type II DM
Aspirin for primary prevention in cad in type II DM
Pijush Kanti Mandal
 

What's hot (20)

The Role of Statins in Ischaemic Stroke
The Role of Statins in Ischaemic Stroke The Role of Statins in Ischaemic Stroke
The Role of Statins in Ischaemic Stroke
 
What next after metformin dpp4 vs su
What next after metformin dpp4 vs suWhat next after metformin dpp4 vs su
What next after metformin dpp4 vs su
 
Aspirin use for the primary prevention of cardiovascular disease and colorect...
Aspirin use for the primary prevention of cardiovascular disease and colorect...Aspirin use for the primary prevention of cardiovascular disease and colorect...
Aspirin use for the primary prevention of cardiovascular disease and colorect...
 
Managing CV risk in Inflammatory Arthritis (Focusing on Gout)
Managing CV risk in Inflammatory Arthritis (Focusing on Gout)Managing CV risk in Inflammatory Arthritis (Focusing on Gout)
Managing CV risk in Inflammatory Arthritis (Focusing on Gout)
 
Managing the Myths in Lipid Management
Managing the Myths in Lipid ManagementManaging the Myths in Lipid Management
Managing the Myths in Lipid Management
 
Terapeuticas hormonais ...sesimbra
Terapeuticas hormonais ...sesimbraTerapeuticas hormonais ...sesimbra
Terapeuticas hormonais ...sesimbra
 
Aspirin as Prevention Therapy for Cardiovascular Events in patients with Diab...
Aspirin as Prevention Therapy for Cardiovascular Events in patients with Diab...Aspirin as Prevention Therapy for Cardiovascular Events in patients with Diab...
Aspirin as Prevention Therapy for Cardiovascular Events in patients with Diab...
 
New Year, New You: Give 2012 a Heart Healthy Start!
New Year, New You: Give 2012 a Heart Healthy Start!New Year, New You: Give 2012 a Heart Healthy Start!
New Year, New You: Give 2012 a Heart Healthy Start!
 
dyslipidemia
dyslipidemiadyslipidemia
dyslipidemia
 
Cardiac risk evaluation: searching for the vulnerable patient
Cardiac risk evaluation: searching for the vulnerable patient Cardiac risk evaluation: searching for the vulnerable patient
Cardiac risk evaluation: searching for the vulnerable patient
 
ACC/AHA lipid guidelines 2018
ACC/AHA lipid guidelines 2018ACC/AHA lipid guidelines 2018
ACC/AHA lipid guidelines 2018
 
Cardio updates 2019 power point template
Cardio updates 2019 power point templateCardio updates 2019 power point template
Cardio updates 2019 power point template
 
Erectile Dysfunction
Erectile DysfunctionErectile Dysfunction
Erectile Dysfunction
 
Heart Failure in Women: More than EF?
Heart Failure in Women: More than EF?Heart Failure in Women: More than EF?
Heart Failure in Women: More than EF?
 
Iron deficiency in Heart Failure - Trial evidence
Iron deficiency in Heart Failure - Trial evidenceIron deficiency in Heart Failure - Trial evidence
Iron deficiency in Heart Failure - Trial evidence
 
Cardiac risk evaluation
Cardiac risk evaluationCardiac risk evaluation
Cardiac risk evaluation
 
Macro complications 2018
Macro complications 2018Macro complications 2018
Macro complications 2018
 
Strive Teleconf Presentation Oct11 2006
Strive Teleconf Presentation Oct11 2006Strive Teleconf Presentation Oct11 2006
Strive Teleconf Presentation Oct11 2006
 
Aspirin for primary prevention in cad in type II DM
Aspirin for primary prevention in cad in type II DMAspirin for primary prevention in cad in type II DM
Aspirin for primary prevention in cad in type II DM
 
Effects of aspirin for primary prevention in persons with Diabetes mellitus
Effects of aspirin for primary prevention in persons with Diabetes mellitusEffects of aspirin for primary prevention in persons with Diabetes mellitus
Effects of aspirin for primary prevention in persons with Diabetes mellitus
 

Similar to Dr. Maureen McMahon Presents "“Heart Disease and Preventive Measures” at Lupus LA's Annual Patient Education Conference

Hypertension: New Concepts, Guidelines, and Clinical Management Hypertensio...
Hypertension: New Concepts, Guidelines, and Clinical Management 	 Hypertensio...Hypertension: New Concepts, Guidelines, and Clinical Management 	 Hypertensio...
Hypertension: New Concepts, Guidelines, and Clinical Management Hypertensio...
MedicineAndFamily
 
Ueda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toonyUeda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toony
ueda2015
 
Ueda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toonyUeda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toony
ueda2015
 

Similar to Dr. Maureen McMahon Presents "“Heart Disease and Preventive Measures” at Lupus LA's Annual Patient Education Conference (20)

Marc Penn, MD, PhD, FACC - Trials and Tribulations of Assessing CVD Risk in ...
Marc Penn,  MD, PhD, FACC - Trials and Tribulations of Assessing CVD Risk in ...Marc Penn,  MD, PhD, FACC - Trials and Tribulations of Assessing CVD Risk in ...
Marc Penn, MD, PhD, FACC - Trials and Tribulations of Assessing CVD Risk in ...
 
Dyslipidemia -Assessment and management based on evidence
Dyslipidemia -Assessment and management based on evidence  Dyslipidemia -Assessment and management based on evidence
Dyslipidemia -Assessment and management based on evidence
 
Impact of obesity on cardiometabolic risk: Will we lose the battle?
Impact of obesity on cardiometabolic risk: Will we lose the battle?Impact of obesity on cardiometabolic risk: Will we lose the battle?
Impact of obesity on cardiometabolic risk: Will we lose the battle?
 
Dyslipidemia in stroke
Dyslipidemia in stroke  Dyslipidemia in stroke
Dyslipidemia in stroke
 
Hypertensive Dyslipidaemics
Hypertensive DyslipidaemicsHypertensive Dyslipidaemics
Hypertensive Dyslipidaemics
 
2008.02.12 Massie Hyperlipidemia
2008.02.12    Massie   Hyperlipidemia2008.02.12    Massie   Hyperlipidemia
2008.02.12 Massie Hyperlipidemia
 
Pfizer Talk Final
Pfizer Talk FinalPfizer Talk Final
Pfizer Talk Final
 
Hypertension: New Concepts, Guidelines, and Clinical Management Hypertensio...
Hypertension: New Concepts, Guidelines, and Clinical Management 	 Hypertensio...Hypertension: New Concepts, Guidelines, and Clinical Management 	 Hypertensio...
Hypertension: New Concepts, Guidelines, and Clinical Management Hypertensio...
 
Hypertension
HypertensionHypertension
Hypertension
 
Homocysteine
Homocysteine Homocysteine
Homocysteine
 
Cardiovascular disease risk in Rheumatic Diseases
Cardiovascular disease risk in Rheumatic DiseasesCardiovascular disease risk in Rheumatic Diseases
Cardiovascular disease risk in Rheumatic Diseases
 
Ueda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toonyUeda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toony
 
Ueda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toonyUeda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toony
 
ueda2012 do we still need high doses-d.mohammed
ueda2012 do we still need high doses-d.mohammedueda2012 do we still need high doses-d.mohammed
ueda2012 do we still need high doses-d.mohammed
 
Cardiovascular diseased and Rheumatoid arthritis
Cardiovascular diseased and Rheumatoid arthritisCardiovascular diseased and Rheumatoid arthritis
Cardiovascular diseased and Rheumatoid arthritis
 
Heart .pptx
Heart .pptxHeart .pptx
Heart .pptx
 
Rosuvastatin
RosuvastatinRosuvastatin
Rosuvastatin
 
Are All FH patients the same ? Cardiovascular Risk Assessment in Familial Hyp...
Are All FH patients the same ? Cardiovascular Risk Assessment in Familial Hyp...Are All FH patients the same ? Cardiovascular Risk Assessment in Familial Hyp...
Are All FH patients the same ? Cardiovascular Risk Assessment in Familial Hyp...
 
Residual CV risk: what is this? Role of lipids and inflammation and how to id...
Residual CV risk: what is this? Role of lipids and inflammation and how to id...Residual CV risk: what is this? Role of lipids and inflammation and how to id...
Residual CV risk: what is this? Role of lipids and inflammation and how to id...
 
Polypill for primary and secondary preventions of cardiovascular
Polypill for primary and secondary preventions of cardiovascularPolypill for primary and secondary preventions of cardiovascular
Polypill for primary and secondary preventions of cardiovascular
 

More from LupusNY

Bag ppt for website 3.14.14
Bag ppt for website  3.14.14Bag ppt for website  3.14.14
Bag ppt for website 3.14.14
LupusNY
 
Bag ppt for website 3.14.14
Bag ppt for website  3.14.14Bag ppt for website  3.14.14
Bag ppt for website 3.14.14
LupusNY
 
Dr. johnson slide presentation 12.13
Dr. johnson slide presentation 12.13Dr. johnson slide presentation 12.13
Dr. johnson slide presentation 12.13
LupusNY
 
Lupus.and.bonehealth
Lupus.and.bonehealthLupus.and.bonehealth
Lupus.and.bonehealth
LupusNY
 
Sle body meds.onome
Sle body meds.onomeSle body meds.onome
Sle body meds.onome
LupusNY
 
State of Lupus Treatment: New Therapeutics
State of Lupus Treatment: New TherapeuticsState of Lupus Treatment: New Therapeutics
State of Lupus Treatment: New Therapeutics
LupusNY
 
Lupus foundation educational program 2013
Lupus foundation educational program 2013Lupus foundation educational program 2013
Lupus foundation educational program 2013
LupusNY
 
Lupus and the heart
Lupus and the heartLupus and the heart
Lupus and the heart
LupusNY
 
Lupus and dental issues
Lupus and dental issuesLupus and dental issues
Lupus and dental issues
LupusNY
 
Lupus and cardiovascular disease
Lupus and cardiovascular diseaseLupus and cardiovascular disease
Lupus and cardiovascular disease
LupusNY
 
Lupus and your kidneys
Lupus and your kidneysLupus and your kidneys
Lupus and your kidneys
LupusNY
 
Managing Lupus and Maintaining a Healthy Lifestyle
Managing Lupus and Maintaining a Healthy LifestyleManaging Lupus and Maintaining a Healthy Lifestyle
Managing Lupus and Maintaining a Healthy Lifestyle
LupusNY
 
Biomarkers for Disease Flare by Emily Baechler Gillespie
Biomarkers for Disease Flare by Emily Baechler Gillespie Biomarkers for Disease Flare by Emily Baechler Gillespie
Biomarkers for Disease Flare by Emily Baechler Gillespie
LupusNY
 

More from LupusNY (20)

Bag ppt for website 3.14.14
Bag ppt for website  3.14.14Bag ppt for website  3.14.14
Bag ppt for website 3.14.14
 
Bag ppt for website 3.14.14
Bag ppt for website  3.14.14Bag ppt for website  3.14.14
Bag ppt for website 3.14.14
 
Dr. johnson slide presentation 12.13
Dr. johnson slide presentation 12.13Dr. johnson slide presentation 12.13
Dr. johnson slide presentation 12.13
 
Skin Care, Weight Control, and Feeling Good with Lupus
Skin Care, Weight Control, and Feeling Good with LupusSkin Care, Weight Control, and Feeling Good with Lupus
Skin Care, Weight Control, and Feeling Good with Lupus
 
Lupus.and.bonehealth
Lupus.and.bonehealthLupus.and.bonehealth
Lupus.and.bonehealth
 
Sle body meds.onome
Sle body meds.onomeSle body meds.onome
Sle body meds.onome
 
2013 New York Bag Ladies Luncheon
2013 New York Bag Ladies Luncheon2013 New York Bag Ladies Luncheon
2013 New York Bag Ladies Luncheon
 
State of Lupus Treatment: New Therapeutics
State of Lupus Treatment: New TherapeuticsState of Lupus Treatment: New Therapeutics
State of Lupus Treatment: New Therapeutics
 
Lupus foundation educational program 2013
Lupus foundation educational program 2013Lupus foundation educational program 2013
Lupus foundation educational program 2013
 
Lupus and the heart
Lupus and the heartLupus and the heart
Lupus and the heart
 
Dialysis and Transplant for Lupus Nephritis
Dialysis and Transplant for Lupus NephritisDialysis and Transplant for Lupus Nephritis
Dialysis and Transplant for Lupus Nephritis
 
Get Into the Loop - Learn About Lupus
Get Into the Loop - Learn About Lupus Get Into the Loop - Learn About Lupus
Get Into the Loop - Learn About Lupus
 
Lupus Treatment and Rehabilitation
Lupus Treatment and RehabilitationLupus Treatment and Rehabilitation
Lupus Treatment and Rehabilitation
 
Lupus: Why am I hurting?
Lupus: Why am I hurting?Lupus: Why am I hurting?
Lupus: Why am I hurting?
 
Lupus and dental issues
Lupus and dental issuesLupus and dental issues
Lupus and dental issues
 
Lupus and cardiovascular disease
Lupus and cardiovascular diseaseLupus and cardiovascular disease
Lupus and cardiovascular disease
 
Lupus and your kidneys
Lupus and your kidneysLupus and your kidneys
Lupus and your kidneys
 
Managing Lupus and Maintaining a Healthy Lifestyle
Managing Lupus and Maintaining a Healthy LifestyleManaging Lupus and Maintaining a Healthy Lifestyle
Managing Lupus and Maintaining a Healthy Lifestyle
 
Lupus and Your Eyes
Lupus and Your EyesLupus and Your Eyes
Lupus and Your Eyes
 
Biomarkers for Disease Flare by Emily Baechler Gillespie
Biomarkers for Disease Flare by Emily Baechler Gillespie Biomarkers for Disease Flare by Emily Baechler Gillespie
Biomarkers for Disease Flare by Emily Baechler Gillespie
 

Recently uploaded

THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
DR SETH JOTHAM
 

Recently uploaded (20)

TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
 
Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgery
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatment
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
 
Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from home
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal Testimony
 
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptxTemporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
 
End Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feelEnd Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feel
 

Dr. Maureen McMahon Presents "“Heart Disease and Preventive Measures” at Lupus LA's Annual Patient Education Conference

  • 1. Atherosclerosis in Systemic Lupus Erythematosus Maureen McMahon, MD, MCR Assistant Professor of Medicine David Geffen School of Medicine UCLA
  • 2. Overall Survival in Lupus has Improved Gabriel, S. et al., Arthritis Rheum 1999;42:46-50. 1950-1979 1980-1992
  • 3. Late Deaths in SLE are due to Heart Disease (Atherosclerosis) Abu-Shakra M, et al. J Rheum. 1995;22:1265–1270. [Evidence Level B]
  • 4. There is an Increased Risk for Atherosclerosis (ATH) in SLE CVA = cerebrovascular accident. Esdaile JM, et al. Arthritis Rheum . 2001;44:2331–2337 [Evidence Level B]; Karrar A, et al. Semin Arthritis Rheum . 2001;30:436–443 [Evidence Level C]; Manzi S, et al. Am J Epidemiol . 1997;145:408–415 [Evidence Level B]; Manzi S, et al. Arthritis Rheum . 1999;42:51–60. [Evidence Level B]
  • 5. Prevalence of ATH Plaque Among Control Subjects and Patients With SLE, According to Decade of Life Roman MJ, et. al. N Engl J Med . 2003;349:2399–2406. [Evidence Level B]  4th 5th 6th  7th Decade of Age P = .009 P = .01 P = .001 P = .08
  • 6. Why do SLE patients have an increased risk of Heart Disease?
  • 7. Patients with SLE Do Have Traditional Cardiac Risk Factors Petri et al. Medicine 1992
  • 8. Traditional Risk Factors Do Contribute to ATH in SLE % of patients with plaque, age adjusted p=0.05 p=0.0001 p=0.07 Maksimowicz-McKinnon et al. J Rheum 2006
  • 9. SLE Disease Activity Influences Standard Lipid Levels Posadas-Romero et al. Arthritis Rheum . 2004;50:160-165 .
  • 10.
  • 11.
  • 12.  
  • 13.
  • 14.
  • 15. LDL: the “Bad Cholesterol” LDL Mackness MI et al. Biochem J 1993. Lipids Online 2004 (Baylor) Blood Vessel White Blood Cells: Monocytes White Blood Cell: Macrophage HDL are anti-inflammatory Foam Cell HDL Remove “Bad Cholesterol” HDL Prevent Oxidation of LDL Oxidized LDL PLAQUE
  • 16.
  • 17.  
  • 18.
  • 19. 45% of SLE patients have pro-inflammatory HDL
  • 20. Pro-inflammatory HDL may be associated with heart disease 4 patients with a history of heart attack were included (all patients had SLE): All 4 had pro-inflammatory HDL!
  • 21.
  • 22.  
  • 23. 86% of SLE patients with ATH have piHDL * Chi-squared or Fisher’s Exact
  • 24.
  • 25.
  • 26.
  • 27. What Can Lupus Patients Do to Decrease Their Risk of Heart Disease?
  • 28.
  • 29.
  • 30. NIH CV Risk Calculator
  • 32.  
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40. Acknowledgements UCLA Rheumatology Bevra Hahn, M.D. Christina Charles, M.D. Jennifer Grossman, M.D. John FitzGerald, M.D., Ph.D. Weiling Chen, M.S. UCLA Cardiology Alan Fogelman, M.D. Mohamad Navab, Ph.D. Cedars-Sinai Medical Center Daniel Wallace, M.D. Michael Weisman, M.D. UCLA Radiology Nagesh Ragavendra, M.D. Funding Organizations Lupus Research Institute Alliance for Lupus Research The Arthritis Foundation